Suppr超能文献

[血管紧张素转换酶抑制剂与心力衰竭中的水代谢]

[ACE-inhibitors and water metabolism in heart failure].

作者信息

Guazzi M D

机构信息

Istituto di Cardiologia, Università degli Studi, Milano.

出版信息

Cardiologia. 1994 Dec;39(12 Suppl 1):133-8.

PMID:7634256
Abstract

At least theoretically, ACE-inhibitors may influence each of the factors involved in the regulation of salt and water metabolism. Angiotensin II exerts an antidiuretic and antinatriuretic action on the kidney through influences on the glomerular filtration coefficient, glomerular filtration rate, mesangial tone, filtration fraction, proximal and distal tubule. Angiotensin II and renin also regulate the input of water and salt through an unequivocal dipsogenic effect. In congestive heart failure angiotensin II participates in the preservation of the glomerular filtration rate through its vasoconstrictor properties on the systemic vessels (maintenance of the perfusion and filtration pressure) as well as on the efferent arteriole (maintenance of the filtration pressure). ACE-inhibition weakens or abolishes these influences. However, two favorable mechanisms may also come into action: rise of cardiac output and improvement in renal blood flow; widening of the filtration surface and increment of the filtration coefficient. The efficacy of these factors depends on renal function, age, functional recovery of the heart, treatment with diuretics, duration of treatment with ACE-inhibitors, duration of action of the ACe-inhibitor used, blockade of the facilitating action on the adrenergic vasoconstriction, formation of vasodilating prostaglandins, reduced degradation of kinins. All these effects may account for the variable and often contradictory clinical results, in particular as concerns the relationship between ACE-inhibition and use of diuretics in congestive heart failure. This also explains the variability of efficacy (from the development of pulmonary edema and requirement of diuretics to diuretic withdrawal and clinical improvement) of the ACE-inhibitors as monotherapy in mild to moderate heart failure.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

至少在理论上,血管紧张素转换酶抑制剂(ACE抑制剂)可能会影响参与盐和水代谢调节的每一个因素。血管紧张素II通过影响肾小球滤过系数、肾小球滤过率、系膜张力、滤过分数、近端和远端肾小管,对肾脏发挥抗利尿和抗利钠作用。血管紧张素II和肾素还通过明确的致渴作用来调节水和盐的摄入。在充血性心力衰竭中,血管紧张素II通过其对全身血管的血管收缩特性(维持灌注和滤过压力)以及对出球小动脉的作用(维持滤过压力)来参与肾小球滤过率的维持。ACE抑制会削弱或消除这些影响。然而,也可能会启动两种有利机制:心输出量增加和肾血流量改善;滤过面积扩大和滤过系数增加。这些因素的疗效取决于肾功能、年龄、心脏功能恢复情况、利尿剂治疗、ACE抑制剂治疗持续时间、所用ACE抑制剂的作用持续时间、对肾上腺素能血管收缩促进作用的阻断、血管舒张性前列腺素的形成、激肽降解减少。所有这些效应可能解释了临床上多变且常常相互矛盾的结果,特别是在充血性心力衰竭中ACE抑制与利尿剂使用之间的关系方面。这也解释了ACE抑制剂作为轻度至中度心力衰竭单一疗法时疗效的变异性(从肺水肿的发生和对利尿剂的需求到利尿剂停用和临床改善)。(摘要截选至250词)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验